TY - JOUR
T1 - Characterization of distinct subpopulations of hepatic macrophages in HFD/obese mice
AU - Morinaga, Hidetaka
AU - Mayoral, Rafael
AU - Heinrichsdorff, Jan
AU - Osborn, Olivia
AU - Franck, Niclas
AU - Hah, Nasun
AU - Walenta, Evelyn
AU - Bandyopadhyay, Gautam
AU - Pessentheiner, Ariane R.
AU - Chi, Tyler J.
AU - Chung, Heekyung
AU - Bogner-Strauss, Juliane G.
AU - Evans, Ronald M.
AU - Olefsky, Jerrold M.
AU - Oh, Dayoung
N1 - Funding Information:
Funding. This study was funded in part by the Marshall Plan Scholarship to A.R.P., Austrian Science Fund (FWF) (FWF Doktoratskolleg DK-MCD W1226 and the FWF project P24143) to J.G.B.-S., and by grants to J.M.O. (DK-033651, DK- 074868, DK-063491, DK-09062) and D.Y.O. (P30-DK-063491). The UCSD Microscope Resource for Microscopy Analysis was funded by UCSD Neuroscience Microscopy Shared Facility Grant P30-NS-047101.
Publisher Copyright:
© 2015 by the American Diabetes Association.
PY - 2015/4
Y1 - 2015/4
N2 - The current dogma is that obesity-associated hepatic inflammation is due to increased Kupffer cell (KC) activation. However, recruited hepatic macrophages (RHMs) were recently shown to represent a sizable liver macrophage population in the context of obesity. Therefore, we assessed whether KCs and RHMs, or both, represent the major liver inflammatory cell type in obesity. We used a combination of in vivo macrophage tracking methodologies and adoptive transfer techniques in which KCs and RHMs are differentially labeled with fluorescent markers. With these approaches, the inflammatory phenotype of these distinct macrophage populations was determined under lean and obese conditions. In vivo macrophage tracking revealed an approximately sixfold higher number of RHMs in obese mice than in lean mice, whereas the number of KCs was comparable. In addition, RHMs comprised smaller size and immature, monocyte-derived cells compared with KCs. Furthermore, RHMs from obese mice were more inflamed and expressed higher levels of tumor necrosis factor-a and interleukin-6 than RHMs from lean mice. A comparison of the MCP-1/C-C chemokine receptor type 2 (CCR2) chemokine system between the two cell types showed that the ligand (MCP-1) is more highly expressed in KCs than in RHMs, whereas CCR2 expression is approximately fivefold greater in RHMs. We conclude that KCs can participate in obesity-induced inflammation by causing the recruitment of RHMs, which are distinct from KCs and are not precursors to KCs. These RHMs then enhance the severity of obesity-induced inflammation and hepatic insulin resistance.
AB - The current dogma is that obesity-associated hepatic inflammation is due to increased Kupffer cell (KC) activation. However, recruited hepatic macrophages (RHMs) were recently shown to represent a sizable liver macrophage population in the context of obesity. Therefore, we assessed whether KCs and RHMs, or both, represent the major liver inflammatory cell type in obesity. We used a combination of in vivo macrophage tracking methodologies and adoptive transfer techniques in which KCs and RHMs are differentially labeled with fluorescent markers. With these approaches, the inflammatory phenotype of these distinct macrophage populations was determined under lean and obese conditions. In vivo macrophage tracking revealed an approximately sixfold higher number of RHMs in obese mice than in lean mice, whereas the number of KCs was comparable. In addition, RHMs comprised smaller size and immature, monocyte-derived cells compared with KCs. Furthermore, RHMs from obese mice were more inflamed and expressed higher levels of tumor necrosis factor-a and interleukin-6 than RHMs from lean mice. A comparison of the MCP-1/C-C chemokine receptor type 2 (CCR2) chemokine system between the two cell types showed that the ligand (MCP-1) is more highly expressed in KCs than in RHMs, whereas CCR2 expression is approximately fivefold greater in RHMs. We conclude that KCs can participate in obesity-induced inflammation by causing the recruitment of RHMs, which are distinct from KCs and are not precursors to KCs. These RHMs then enhance the severity of obesity-induced inflammation and hepatic insulin resistance.
UR - http://www.scopus.com/inward/record.url?scp=84962026512&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84962026512&partnerID=8YFLogxK
U2 - 10.2337/db14-1238
DO - 10.2337/db14-1238
M3 - Article
C2 - 25315009
AN - SCOPUS:84962026512
SN - 0012-1797
VL - 64
SP - 1120
EP - 1130
JO - Diabetes
JF - Diabetes
IS - 4
ER -